Disease overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Representing the major cause of morbidity and mortality for chronic lymphocytic leukemia
(CLL) patients, immunosuppression is a common feature of the disease. Effectors of the …

Background Genome-edited donor-derived allogeneic anti-CD19 chimeric antigen receptor
(CAR) T cells offer a novel form of CAR-T-cell product that is available for immediate clinical …

P neumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with
cancer‐related immunosuppression. There are well‐defined patients who are at risk of PJP …

Abstract Disease Overview Cutaneous T‐cell lymphomas (CTCL) are a heterogenous group
of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis …

Patients with cancer are at increased risk for developing infectious complications during the
course of their disease and treatment. The following sections of the NCCN Clinical Practice …

Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐
cell neoplasms involving the skin, the majority of which may be classified as Mycosis …

Morbidity and mortality caused by invasive Aspergillus infections are increasing. This is
because of the higher number of patients with malignancies treated with intensive …

Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …

Safety and efficacy of the fully human anti-CD20 monoclonal antibody, ofatumumab, was
analyzed in a multicenter dose-escalating study including 33 patients with relapsed or …